medRxiv · Oct 24, 2026
Glucoregulatory and Inflammatory Trajectories in Pregnancy with Obesity: Secondary Analysis of a Randomized Exercise Trial
By Jansen LT, Chung S, Caldwell AR et al.
Objective: To evaluate moderate-intensity exercise effects on glucoregulatory and inflammatory markers in pregnant women with obesity. Methods: Secondary analysis of the Expecting Study (NCT02125149) included 263 sedentary pregnant women with pre-pregnancy BMI [≥]30kg/m2 randomized to exercise (EX, n=157) or standard-of-care (SoC, n=106). Fasting biomarkers were assessed at 12.14{+/-}0.50, 24.19{+/-}0.68, and 36.03{+/-}0.58 weeks ' gestation. Linear mixed-effects models evaluated intervention and gestational effects at 24-36 weeks. Exploratory repeated-measures continuous glucose monitoring (CGM) included 18 participants (SoC=6, EX=12), evaluating 24-h/temporal glycemia and exploring inflammatory marker associations. Results: Insulin, C-peptide, HOMA2-IR, HOMA2-%B, IL-6, and TNF- increased with gestation, while HOMA2-%S and CRP decreased (all p<0.001). Exercise did not affect fasting glucose or inflammatory markers. CGM-wear yielded 12-15 days/trimester with >95% valid wear time; glycemia remained normoglycemic. By 36-weeks, SoC-metrics declined in 24-h and nocturnal glucose and time-in-range (TIR), with increased time-below-range (all p<0.022). TIR was inversely associated with IL-6 at 24-weeks (-0.23 [95%CI: -0.43,-0.02] p=0.035), and mean amplitude of glycemic excursion positively with TNF- at 36-weeks (0.02 [95%CI: 0.00,0.04] p=0.033). Conclusion: Exercise did not modify mid-to late-gestation fasting glucoregulatory or inflammatory profiles. High CGM-adherence and preliminary indications of distinct longitudinal glycemic patterns support further CGM evaluation in antepartum behavioral interventions.
doi.org/10.64898/2026.10.21.26366153Open accessInterventions